Skip to content

Fontan-velocity study: Four-dimensional blood flow MRI analysis in patients with a Fontan circulation

Fontan-velocity study: Four-dimensional blood flow MRI analysis in patients with a Fontan circulation - Fontan-Velocity study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46653
Enrollment
90
Registered
2018-08-20
Start date
2018-03-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

single ventricle Univentricular heart

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with an intact Fontan-TCPC circulation performed at the LUMC >8years of age No contra-indications for exercise test No contra-indications for MRI examination

Exclusion criteria

Exclusion criteria: Claustrophobia Contraindication for MRI

Design outcomes

Primary

MeasureTime frame
Echocardiographic parameters: Cardiac index MRI parameters: Cardiac and Fontan tunnel: Flow patterns and Energetics (energy loss) Liver: Liver Multi-scan (fat, iron, fibrosis level) Exercise test parameters: peak oxygen uptake (VO2 max) Stool parameter: alpha-1 antitrypsin Clinical parameters: NYHA class Episodes of PLE in history Holter: Arrythmias

Secondary

MeasureTime frame
Echocardiographic parameters: ejection fraction, grading of AVV regurgitation, E/A ratio, propagation velocity MRI parameters: Cardiac: End diastolic volume (EDV), End systolic volume (ESV), single ventricle ejection fraction (EF), quantification of AVV regurgitation Cardiac and Fontan tunnel: Energetics (kinetic energy, turbulent kinetic energy, vorticity, wall shear stress) Exercise test parameters: Peak heart rate, percentage of expected Watts. Blood parameters: complete blood count liver function kidney function albumin and total protein NT-proBNP, hs-TnT, GDF-15 Urine parameter: Protein Clinical parameters: Time from Fontan operation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)